Evidence map›Paper›PMID 42470585›Full record

ArticleNeurotoxicity research2026

C-terminal Domain of the Heavy Chain of Tetanus Toxin Ameliorate Lipopolysaccharide Induced Hemiparkinsonism in Rats.

Irving Parra, José Aguilera, Yousef Tizabi, Liliana Mendieta

Erratum issuedAbstract read
In one paragraph

Article in Neurotoxicity research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Irving ParraLaboratorio de Neuroquímica, Facultad de Ciencias Químicas, Benemérita Universidad Autónoma de Puebla, 14 Sur y Av. San Claudio CU, Col. San Manuel, Puebla, 72592, México.ORCID http://orcid.org/0009-0003-9312-3244
José AguileraDepartament de Bioquímica i Biologia Molecular, Institut de Neurociències, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, 08193, España.ORCID http://orcid.org/0000-0002-9906-8034
Yousef TizabiDepartment of Pharmacology, Howard University College of Medicine, Washington, DC, USA.ORCID http://orcid.org/0000-0003-1703-1842
Liliana MendietaLaboratorio de Neuroquímica, Facultad de Ciencias Químicas, Benemérita Universidad Autónoma de Puebla, 14 Sur y Av. San Claudio CU, Col. San Manuel, Puebla, 72592, México. liliana.martinezmen@correo.buap.mx.ORCID http://orcid.org/0000-0001-6049-2770

Funding

Instituto de Salud Carlos III CIBERNED CB06/05/0042International Brain Research Organization IBRO Parenthood GrantMinisterio de Ciencia, Innovación y Universidades PID2022-137668OB-I00Secretaría de Ciencia, Humanidades, Tecnología e Innovación Ciencia de Frontera CF-G133Vicerrectoría de Investigación y Estudios de Posgrado-BUAP PV-828
6 · The paper itself

Abstract

Neuroinflammation is recognized as a central mechanism in Parkinson's disease (PD) pathogenesis. The C-terminal domain of the heavy-chain of tetanus toxin (Hc-TeTx) has shown neuroprotective effects in toxin-based PD models, but its efficacy in inflammatory-induced PD conditions remain unexplored. To test this possibility, we used the hemiparkinsonism model induced by central injection of lipopolysaccharide (LPS) to evaluate potential antiinflammatory effects of Hc-TeTx in adult male Wistar rats. Seven days post LPS-injection motor coordination and gait maintenance were assessed using elevated beam test. The day after, that is 8 days post LPS-injection, the cylinder test was used to assess forelimb motor asymmetry during spontaneous vertical exploration. Immediately after this test the animals were sacrificed for tissue collection. Dopaminergic degeneration was assessed by immunohistochemical quantification of tyrosine hydroxylase in substantia nigra pars compacta. Astroglial activation, reflective of neuroinflammation was evaluated by glial fibrillary acidic protein in the striatum. LPS administration caused forelimb motor asymmetry, which was significantly attenuated by Hc-TeTx treatment. Hc-TeTx also tended to attenuate LPS-induced dopaminergic neurodegeneration reflected by a reduced TH ipsilateral/contralateral ratio, as well as astroglial activation that was markedly increased after LPS administration. Beam test parameters showed no significant differences among groups. Although further verification and mechanistic studies are needed, current results support potential utility of Hc-TeTx in an inflammatory model of PD.

Indexed as

LipopolysaccharidesNeuroprotective AgentsParkinsonian DisordersPeptide FragmentsTetanus ToxinAnimalsDisease Models, AnimalFunctional LateralityMaleRatsRats, WistarTyrosine 3-MonooxygenaseLipopolysaccharidesNeuroprotective AgentsPeptide FragmentsTetanus Toxintetanus toxin fragment CTyrosine 3-MonooxygenaseAstrogliaLipopolysaccharideNeuroinflammationParkinson’s disease modelRatTetanus toxin

Identifiers

PMID42470585
PMCPMC13380572

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.